Anonymous ID: 3e6d56 April 23, 2020, 5:23 p.m. No.8902656   🗄️.is 🔗kun

>>8902493

 

January 2017 Bill and Melinda Gates Foundation established an international vaccine "research" organization CEPI, Coalition for Epidemic Preparedness Innovations.

 

HR 6334 Securing America From Epidemics Act

Would require the Executive to establish a plan to work with with CEPI on research. Basically, an open value sole source contract with the Gates Foundation.

 

https://www.congress.gov/bill/116th-congress/house-bill/6334/text

 

CEPI website: https://cepi.net/

(not very informative as is typical of globalist sites, larege lettering, few well crafted statements but without substance).

 

Coalition for Epidemic Preparedness Innovations CEPI wiki page:

https://en.wikipedia.org/wiki/Coalition_for_Epidemic_Preparedness_Innovations

Anonymous ID: 3e6d56 April 23, 2020, 5:36 p.m. No.8902792   🗄️.is 🔗kun

>>8902719

 

Related BBC article

 

In Mehico, they should educate the tress on social distancing and give them masks.

 

Volcanic time-bomb threatens nearby trees

https://www.bbc.com/news/science-environment-52400686

Trees growing near to an active volcano face an uncertain future for several years after an eruption, a study has suggested.

 

A reduced ability to absorb essential nutrients from the soil and lower rates of turning sunshine into sugar hampered the trees' growth.

 

A team of researchers also found that toxins released by eruptions continued to limit the trees' growth.

 

The findings appear in the journal Dendrochronologia.

 

The team said that the widespread impact of volcanic eruptions on trees had been well documented, such as the "year without a summer" in 1816, following the massive Tambora eruption in Indonesia in the previous year, which was deemed to be the biggest volcanic eruption in human history.

 

However, they added, there was little known about the effect eruptions had on surviving trees near to volcanoes.

 

Danger depletes data

Certain things had been observed, such as damage to the tree's branches, dust covering the foliage reducing the trees ability to photosynthesise and grow.

 

But few studies had been carried out and meaningful data collated.

 

The team of Spanish and Mexican scientists decided to assess the effects of eruptions on a volcano in central Mexico, which had become active again at the turn of the millennium.

 

The mount, called Popocatepetl (which translates as Smoking Mountain), is about 70km south-east of Mexico City. It's the country's second highest peak.

 

"We selected a study area with living trees growing at the upper forest limit of the Popocatepetl, approximately 4,000 metres above sea-level," explained co-author Raquel Alfaro-Sanchez.

 

"For this study, we focused on the response of the trees to the largest eruption recorded since the volcano resumed its eruptive activities in 1994. This occurred in December 2000."

 

During the decade following the resumption of eruptions in 1994, tree ring samples showed the team that the trees had experienced reduced effectiveness of pores on the leaves (stomata) as well as reduce photosynthetic activity as a "consequence of reduced light intensity [as a result of] the large dust layer covering the study area".

 

Dr Alfaro-Sanchez added the samples revealed something else: "Immediately after the December 2000 eruption, and compared with the pre-eruptive period (1989-1993), we detected an increase in the concentration of some metal elements."

 

A large reduction in growth was also recorded in 2003, three years after the large eruption of 2000, she told BBC News.

 

"This sharp reduction of growth was probably caused by the negative effect of the two years of reduced photosynthetic capacity and the increase in concentration of potentially toxic elements, such as aluminium, lead and rubidium," she said.

 

Well suited, ill-suited

Hartweg pines (Pinus hartwegii) are native to the mountains of central Mexico, and are a high altitude specialist, able to grow and thrive at 2,500-4,300 metres above seal-level.

 

It was this species that dominated the study area.

 

Uncertain future

"This species is adapted to low temperatures and water availability," Dr Alfaro-Sanchez explained.

 

"It is also adapted to deal with frequent low intensity fires. Some of the adaptations to fires are a thick bark and a high recovery from crown scorching."

 

Yet while the species had been ideally placed to recolonise the area following an eruption, she sounded a note of caution.

 

"An increase in the volcanic activity (including very frequent fires) together with an increase in drought events as a result of climate change could favour grass species to the detriment of the pine," she said.

 

Dr Alfaro-Sanchez described the volcano as one of the most astonishing places she had worked.

 

"The contrast of colours between the ashen-grey soils and the snow and the vegetation was outstanding. I always had an eye on the volcano; when there were no clouds it had a visible ash plume above the crater and, occasionally, you could hear low intensity explosions," she recalled.

 

"It was totally safe but I still found it pretty unsettling."

 

Since the study was carried out, the volcanic activity on the smoky mountain has increased and it is now no longer safe for scientists to return to the study area.

Anonymous ID: 3e6d56 April 23, 2020, 6:04 p.m. No.8903048   🗄️.is 🔗kun   >>3108 >>3192

>>8902871

 

Former US Federal Vaccine Agency Chief Files Whistleblower Complaint For ‘Retaliatory’ Demotion

(sputniknews April 23 2020)

https://sputniknews.com/us/202004231079072670-former-us-federal-vaccine-agency-chief-files-whistleblower-complaint-for-retaliatory-demotion/

 

Dr. Rick Bright, who was removed on Tuesday from his positions as both the Director of the Biomedical Advanced Research and Development Authority (BARDA) and as the HHS Deputy Assistant Secretary for Preparedness and Response, has alleged that his demotion to a “less impactful” position was inspired by White House politics.

 

The former leader of the US federal vaccine agency, Dr. Rick Bright, is planning to file a whistleblower complaint with the US Department of Health and Human Services (HHS) attorney general and the Office of Special Counsel over “retaliatory treatment” he suffered following his criticism of US President Donald Trump’s promotion of hydroxychloroquine as a cure for the COVID-19 disease, attorneys said in statement.

 

“We will soon be filing a whistleblower complaint with both the Office of Special Counsel and the HHS Inspector General on behalf of Dr. Rick Bright detailing the retaliatory treatment to which he was subjected by HHS political leadership after raising science-based concerns about White House pressure on treatment and vaccines related to the COVID-19 pandemic,” the statement read.

 

Bright’s lawyers, Debra S. Katz and Lisa J. Banks, said that the HHS is currently making “demonstrably false statements” about the health expert in a bid to “deflect attention from its retaliatory removal of him” from office.

 

“Dr. Bright was sidelined for one reason only – because he resisted efforts to provide unfettered access to potentially dangerous drugs, including chloroquine, a drug promoted by the Administration as a panacea, but which is untested and possibly deadly when used improperly,” the attorneys stated.

Katz and Banks said that documents supporting Bright’s concerns about the untested drug will soon be released to the public.

 

The attorneys noted that Bright desires to return to his position at BARDA to concentrate on the fight against the ongoing coronavirus pandemic ravaging the country.

 

Trump had previously repeatedly suggested that taking hydroxychloroquine and azithromycin together was an effective treatment to cure COVID-19, claiming that his suggestion could “have a real chance to be one of the biggest game changers in the history of medicine”.

 

On Wednesday, Bright stated in a press release that he was removed from office over his call to resist the adoption of untested drug treatments promoted by the US president and his advisers.

 

other articles linked in story:

US Federal Vaccine Agency Leader Suggests His Demotion Was Political (April 22)

https://sputniknews.com/us/202004221079060801-us-federal-vaccine-agency-leader-suggests-his-demotion-was-political/

 

CIA Warns Workforce Against Anti-Malaria Drug Promoted by Trump for COVID-19 – Report (April 14)

https://sputniknews.com/us/202004141078954774-cia-warns-workforce-against-anti-malaria-drug-promoted-by-trump-for-covid-19—report-/

Anonymous ID: 3e6d56 April 23, 2020, 6:14 p.m. No.8903142   🗄️.is 🔗kun   >>3143

Bread #11393 >>8901128 House passes $484bn coronavirus relief bill for small businesses in bipartisan vote as Democrats launch new investigative panel

 

US House Passes $484 Billion COVID-19 Relief Bill, Trump to Sign

https://sputniknews.com/us/202004231079071697-us-house-passes-484-billion-covid-19-relief-bill-trump-to-sign/

 

With the US House Representatives' vote of 388-5, Congress has passed the “Phase 3.5” relief bill, which dedicates federal funding to hospitals for ramped up COVID-19 novel coronavirus testing and more than $300 billion in bailouts for small businesses.

 

The overwhelmingly bipartisan House vote to advance the legislation comes two days after the Senate unanimously approved the bill via voice vote, allowing lawmakers to remain at home and avoid traveling back to Washington, DC, amid the pandemic.

 

Phase 3.5 now goes to the desk of US President Donald Trump, who expressed Thursday evening that he will likely sign the bill in the coming hours.

 

The $484 billion COVID-19 relief bill amends the bipartisan-backed Coronavirus Aid, Relief, and Economic Security (CARES) Act and provides a $310 billion expansion to the authorization level of the Paycheck Protection Program (PPP) - established to rescue small American businesses through loans subsequently forgiven if all employees remain on payroll for a period of eight weeks and funds are used for payroll, mortgage interests, utilities or rent.

Another $60 billion from the bill has been reserved for small businesses without existing banking relationships. Around $100 billion is earmarked for the Department of Health and Human Services, with $75 billion of that going toward the reimbursement of lost revenue to hospitals and health care providers amid the novel coronavirus pandemic.

 

Rep. Alexandria Ocasio-Cortez (D-NY), who voted against the bipartisan-backed bill, explained that her opposition stemmed from the fact that New Yorkers will not be able to immediately access enhanced Unemployment Insurance benefits and Pandemic Unemployment Assistance provided to state residents under the CARES Act, despite the presence of an undeniably urgent economic crisis for the hard-hit state.

 

"My vote would be different today if we were planning on voting on CARES tomorrow or the week after that in the next two weeks. But the problem is that this is not an interim bill. This is the only bill we are voting on for the entire month of April," she noted, as reported by NBC News' Alex Moe on Twitter.

Earlier, House representatives exhibited a distinct division as Democrats alone approved the formation of the House Oversight and Government Reform Select Subcommittee on the Coronavirus Crisis with a 212-182 vote requiring a simple majority. The Republican opposition to the subcommittee's formation was supported by Rep. Justin Amash (I-MI), a former Republican who left the GOP in July 2019 and is currently the sole member of the House not belonging to one of the two major parties.

 

Hours before the lower house’s vote, House Speaker Nancy Pelosi claimed the subcommittee’s creation was necessary and, in the coming months, will ensure “the federal response is based on the best possible science and guided by health experts, and that the money invested is not being exploited by profiteers and price gougers,” according to the Associated Press.

A number of GOP lawmakers on the House Oversight Committee have argued the subcommittee is a partisan plot to subvert the US president and issue a series of taxpayer-funded political attacks ahead of the 2020 presidential election.

 

Before traveling to their respective homes last month, members of Congress were able to come together to pass the CARES Act, a historic $2.2 trillion COVID-19 stimulus package that was later signed into law by Trump on March 27.

 

(continued)

Anonymous ID: 3e6d56 April 23, 2020, 6:15 p.m. No.8903143   🗄️.is 🔗kun

>>8903142

 

US House Passes $484 Billion COVID-19 Relief Bill, Trump to Sign (continued)

 

The bill provided financial relief to state and territorial governments, funding for the US Centers for Disease Control and Prevention and a notable $1,200 cash payment to single, childless taxpayers who reported annual earnings totaling less than $75,000. Marriage and the number of children claimed by a family were criteria used to determine whether one would receive less or more than the common $1,200 check.

 

Though Americans have expressed that the one-time stimulus check is not sufficient federal aid amid the US’ record unemployment, Senate Majority Leader Mitch McConnell’s recent rhetoric suggested that it is unlikely the upper chamber will pass another novel coronavirus-targeted funding bill before Congress returns from a five-week recess on May 4.

 

“The best way to get the economy back [up] and running is to begin to open it up again, rather than passing immediately another bill where we have to borrow,” McConnell said in a Tuesday phone interview with Politico, arguing that Congress needs to be “cautious” concerning the “extraordinary numbers” being added to the national debt.

Furthermore, public skepticism over the government's accountability has emerged after so-called small business loans were extended to a large chain businesses, such as Shake Shack. A recent Forbes analysis on the PPP’s approval process revealed 71 publicly traded companies managed to snag loans before the program’s initial $350 billion in funding was all claimed.